Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study.
Drug Testing and Analysis September 1, 2024 Verena Angerer, Yasmin Schmid, Florian Franz et al. 6 citations
The acute psychoactive, autonomic, and endocrine effects of the new psychoactive substance (NPS) 5,6-methylenedioxy-2-aminoindane (MDAI; 3.0 mg/kg, range 180-228 mg) were investigated in six healthy volunteers (four males, two females) in a non-blinded fashion without placebo. Subjective, cardiovascular, and endocrine responses were compared with two different doses of...
DOI: 10.1002/dta.3622 (opens in new tab)
Full text (opens in new tab)
Entactogens
New psychoactive substances
Pharmacokinetics
Psychometric